Krystal Biotech (KRYS) SEC Filings: History & Chart

Krystal Biotech, Inc.(KRYS)

Biotechnology · Pittsburgh, PA

$326.17-8.68 (-2.59%)

Delayed quote: Oct 6, 2026, 2:30 PM EDT

About Krystal Biotech, Inc.

Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising programs: KB105 is in Phase I/II clinical trials for patients suffering from deficient autosomal recessive congenital ichthyosis; KB301 is also in Phase I/II development, aiming to ameliorate wrinkles and other signs of aging or damaged skin. Additionally, Krystal Biotech is conducting preclinical research on KB407 for cystic fibrosis and KB104 for Netherton syndrome. In its earlier discovery phase, the company is exploring candidates such as KB5xx for chronic skin conditions and multiple KB3xx programs targeting aesthetic dermatological concerns. Krystal Biotech, Inc. was established in 2015 and is based in Pittsburgh, Pennsylvania.

Pittsburgh, PA

295 employees

www.krystalbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Krish S. Krishnan

View full financials

Form	Filing Date	Accepted	Document
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 4, 2026	Sep 4, 2026	View filing
4	Sep 4, 2026	Sep 4, 2026	View filing
4	Aug 14, 2026	Aug 14, 2026	View filing
8-K	Aug 3, 2026	Aug 3, 2026	View filing
10-Q	Aug 3, 2026	Aug 3, 2026	View filing
8-K	Jul 21, 2026	Jul 21, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 5, 2026	Jun 5, 2026	View filing
4	Jun 5, 2026	Jun 5, 2026	View filing
4	May 27, 2026	May 27, 2026	View filing
144	May 26, 2026	May 26, 2026	View filing
8-K	May 20, 2026	May 19, 2026	View filing
SC 13G/A	May 4, 2026	May 4, 2026	View filing
8-K	May 4, 2026	May 4, 2026	View filing
10-Q	May 4, 2026	May 4, 2026	View filing
SC 13G	Apr 29, 2026	Apr 29, 2026	View filing
ARS	Apr 3, 2026	Apr 3, 2026	View filing
DEFA14A	Apr 3, 2026	Apr 3, 2026	View filing
DEF 14A	Apr 3, 2026	Apr 3, 2026	View filing
SC 13G/A	Mar 27, 2026	Mar 27, 2026	View filing
3	Mar 6, 2026	Mar 6, 2026	View filing
3	Mar 6, 2026	Mar 6, 2026	View filing
4	Mar 6, 2026	Mar 6, 2026	View filing
4	Mar 6, 2026	Mar 6, 2026	View filing

SEC Filings

Recent Filings